台股 » 台康生技 » 個股財報 » 每月營收

台康生技

(6589)
可現股當沖
  • 股價
    69.8
  • 漲跌
    ▼4.7
  • 漲幅
    -6.31%
  • 成交量
    655
  • 產業
    上櫃 生技醫療類股 ▼4.62%
  • 本地時間:13:30(已收盤)

    525人加入追蹤

    立即追蹤

台康生技 (6589) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

台康生技 (6589) 月營收分析比較圖

Created with Highstock 1.3.7台康生技 (6589)嗨投資 histock.tw單月營收去年同月營收月收盤價2020/012021/012022/012023/012024/012025/010100,000200,000300,000400,000500,000050100150200
Created with Highstock 1.3.7台康生技 (6589)嗨投資 histock.tw增減分界單月月增率%月收盤價2020/012021/012022/012023/012024/012025/010200400-200600050100150200
Created with Highstock 1.3.7台康生技 (6589)嗨投資 histock.tw增減分界單月年增率%月收盤價2020/012021/012022/012023/012024/012025/01-25002505007501,000050100150200

台康生技 (6589) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2025/0242,34647,131-15.5%-10.1%92,455161,248-42.7%
2025/0150,109114,117-63.8%-56.1%50,109114,117-56.1%
2024/12138,381106,17444.3%30.3%1,008,9601,022,652-1.3%
2024/1195,927256,36359%-62.6%870,579916,478-5%
2024/1060,33394,029-22.9%-35.8%774,652660,11517.4%
2024/0978,22085,949-4%-9%714,319566,08626.2%
2024/0881,47063,085-8%29.1%636,099480,13732.5%
2024/0788,53362,41745.4%41.8%554,629417,05233%
2024/0660,88252,281-49.4%16.5%466,096354,63531.4%
2024/05120,36552,53584.7%129.1%405,214302,35434%
2024/0465,15733,49711.5%94.5%284,849249,81914%
2024/0358,44465,26924%-10.4%219,692216,3221.5%
2024/0247,13180,999-58.7%-41.8%161,248151,0536.7%
2024/01114,11770,0547.5%62.9%114,11770,05462.9%
2023/12106,174133,101-58.6%-20.2%1,022,6521,481,016-30.9%
2023/11256,363156,658172.6%63.6%916,4781,347,915-32%
2023/1094,029131,5529.4%-28.5%660,1151,191,257-44.6%
2023/0985,949132,65536.2%-35.2%566,0861,059,705-46.6%
2023/0863,08595,7791.1%-34.1%480,137927,050-48.2%
2023/0762,417133,13319.4%-53.1%417,052831,271-49.8%
2023/0652,281108,521-0.5%-51.8%354,635698,138-49.2%
2023/0552,535118,74156.8%-55.8%302,354589,617-48.7%
2023/0433,497109,331-48.7%-69.4%249,819470,876-46.9%
2023/0365,26974,873-19.4%-12.8%216,322361,545-40.2%
2023/0280,99964,74615.6%25.1%151,053286,672-47.3%
2023/0170,054221,926-47.4%-68.4%70,054221,926-68.4%
2022/12133,101193,085-15%-31.1%1,481,0161,697,359-12.7%
2022/11156,658123,98419.1%26.4%1,347,9151,504,274-10.4%
2022/10131,552106,476-0.8%23.5%1,191,2571,380,290-13.7%
2022/09132,65578,90838.5%68.1%1,059,7051,273,814-16.8%
2022/0895,779173,837-28%-44.9%927,0501,194,906-22.4%
2022/07133,133403,86622.7%-67%831,2711,021,069-18.6%
2022/06108,521113,578-8.6%-4.4%698,138617,20313.1%
2022/05118,741142,8978.6%-16.9%589,617503,62517.1%
2022/04109,331115,94046%-5.7%470,876360,72830.5%
2022/0374,87382,96615.6%-9.8%361,545244,78847.7%
〈熱門股〉台康生技美國FDA藥證申請未過 周跌逾2成Anue鉅亨-2024/12/14
台康抗癌生物相似性藥獲歐盟 CHMP 推薦 有望第4季上市UDN聯合新聞網-2023/09/18
台康生技 相關文章
台康生技 相關影音
 
 
610小時34